EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Novel recombinant bovine papular stomatitis virus expressing foot-and-mouth disease virus-like particles elicits neutralizing antibodies in cattle

Herman M. Chambaro, Gustavo Delhon, María Cruz Miraglia, Sabrina Galdo-Novo, Ana Taffarel, Byung-Joon Seung, Sushil Khatiwada, Daniel Mariano Pérez-Filgueira, Daniel L. Rock

Journal of General Virology · 2026-11-02 · 107 (11)

DOI: 10.1099/jgv.0.002344 ↗
AbstractBibliografische Angaben

Abstract

Foot-and-mouth disease (FMD) remains a major burden in endemic regions, where inactivated vaccines are constrained by cost, short duration of immunity, cold-chain dependence and high-containment manufacturing. Here, we engineered a recombinant bovine papular stomatitis virus (rBPSV) expressing the FMD virus (FMDV) A24 Cruzeiro capsid precursor P1-2A together with an attenuated 3C protease (3C proL127P ). Infection of ovine foetal turbinate cells resulted in FMDV capsid protein expression and assembly of 25–30 nm icosahedral virus-like particles (VLPs). Intramuscular immunization of two BPSV-seropositive calves with rBPSV (10 7 TCID 50 on days 0, 21 and 35) induced anti-FMDV humoral responses. By day 28, liquid-phase blocking ELISA titres exceeded laboratory-defined protective threshold (≥1.9 log 10 ), and homologous neutralizing titres against A24 Cruzeiro surpassed the threshold associated with protection (≥1.36 log 10 ). Intra-serotypic cross-neutralization was observed against A/Argentina/2001, whereas no neutralization was detected against heterologous serotype O 1 Campos. Pre-existing anti-BPSV antibodies did not prevent induction of neutralizing responses. These findings establish the first proof of concept that BPSV can serve as a cattle-adapted vector platform for delivery of FMDV VLPs.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →